Alternative Targets for SPLA2 Activity: Role of Membrane-Enzyme Interactions

Overview

Journal Membranes (Basel)

Date 2023 Jul 28

PMID 37504984

Authors

Anna S Alekseeva

Ivan A Boldyrev

Affiliations

Soon will be listed here.

Abstract

The secreted phospholipases A2 (sPLA2s) play important roles both physiologically and pathologically, with their expression increasing significantly in diseases such as sepsis, inflammation, different cancers, glaucoma, obesity, Alzheimer's disease and even COVID-19. The fact has led to a large-scale search for inhibitors of these enzymes. In total, several dozen promising molecules have been proposed, but not a single one has successfully passed clinical trials. The failures in clinical studies motivated in-depth fundamental studies of PLA2s. Here we review alternative ways to control sPLA2 activity, outside its catalytic site. The concept can be realized by preventing sPLA2 from attaching to the membrane surface; by binding to an external protein which blocks sPLA2 hydrolytic activity; by preventing sPLA2 from orienting properly on the membrane surface; and by preventing substrate binding to the enzyme, keeping the catalytic site unaltered. Evidence in the literature is summarized in the review with the aim to serve as a starting point for new types of sPLA2 inhibitors.

References

Boilard E, Bourgoin S, Bernatchez C, Surette M . Identification of an autoantigen on the surface of apoptotic human T cells as a new protein interacting with inflammatory group IIA phospholipase A2. Blood. 2003; 102(8):2901-9. DOI: 10.1182/blood-2002-12-3702. View

Chabot S, Koumanov K, Lambeau G, Gelb M, Balloy V, Chignard M . Inhibitory effects of surfactant protein A on surfactant phospholipid hydrolysis by secreted phospholipases A2. J Immunol. 2003; 171(2):995-1000. DOI: 10.4049/jimmunol.171.2.995. View

Renetseder R, Brunie S, Dijkstra B, Drenth J, SIGLER P . A comparison of the crystal structures of phospholipase A2 from bovine pancreas and Crotalus atrox venom. J Biol Chem. 1985; 260(21):11627-34. View

Nasri Z, Memari S, Wenske S, Clemen R, Martens U, Delcea M . Singlet-Oxygen-Induced Phospholipase A Inhibition: A Major Role for Interfacial Tryptophan Dioxidation. Chemistry. 2021; 27(59):14702-14710. PMC: 8596696. DOI: 10.1002/chem.202102306. View

Thompson P, Nidorf S, Eikelboom J . Targeting the unstable plaque in acute coronary syndromes. Clin Ther. 2013; 35(8):1099-107. DOI: 10.1016/j.clinthera.2013.07.332. View

Rosenson R, Hislop C, McConnell D, Elliott M, Stasiv Y, Wang N . Effects of 1-H-indole-3-glyoxamide (A-002) on concentration of secretory phospholipase A2 (PLASMA study): a phase II double-blind, randomised, placebo-controlled trial. Lancet. 2009; 373(9664):649-58. DOI: 10.1016/S0140-6736(09)60403-7. View

Nicholls S, Kastelein J, Schwartz G, Bash D, Rosenson R, Cavender M . Varespladib and cardiovascular events in patients with an acute coronary syndrome: the VISTA-16 randomized clinical trial. JAMA. 2013; 311(3):252-62. DOI: 10.1001/jama.2013.282836. View

Mattiazzi M, Sun Y, Wolinski H, Bavdek A, Petan T, Anderluh G . A neurotoxic phospholipase A2 impairs yeast amphiphysin activity and reduces endocytosis. PLoS One. 2012; 7(7):e40931. PMC: 3402474. DOI: 10.1371/journal.pone.0040931. View

Berg O, Gelb M, Tsai M, Jain M . Interfacial enzymology: the secreted phospholipase A(2)-paradigm. Chem Rev. 2001; 101(9):2613-54. DOI: 10.1021/cr990139w. View

10.

Nomura K, Fujita H, Arita H . Gene expression of pancreatic-type phospholipase-A2 in rat ovaries: stimulatory action on progesterone release. Endocrinology. 1994; 135(2):603-9. DOI: 10.1210/endo.135.2.8033809. View

11.

Zhuo S, Yuan C . Active site competition is the mechanism for the inhibition of lipoprotein-associated phospholipase A by detergent micelles or lipoproteins and for the efficacy reduction of darapladib. Sci Rep. 2020; 10(1):17232. PMC: 7560626. DOI: 10.1038/s41598-020-74236-0. View

12.

Gelb M, Cho W, Wilton D . Interfacial binding of secreted phospholipases A(2): more than electrostatics and a major role for tryptophan. Curr Opin Struct Biol. 1999; 9(4):428-32. DOI: 10.1016/S0959-440X(99)80059-1. View

13.

Beers S, Buckland A, Koduri R, Cho W, Gelb M, Wilton D . The antibacterial properties of secreted phospholipases A2: a major physiological role for the group IIA enzyme that depends on the very high pI of the enzyme to allow penetration of the bacterial cell wall. J Biol Chem. 2001; 277(3):1788-93. DOI: 10.1074/jbc.M109777200. View

14.

Yu B, Ghomashchi F, Cajal Y, Annand R, Berg O, Gelb M . Use of an imperfect neutral diluent and outer vesicle layer scooting mode hydrolysis to analyze the interfacial kinetics, inhibition, and substrate preferences of bee venom phospholipase A2. Biochemistry. 1997; 36(13):3870-81. DOI: 10.1021/bi961541x. View

15.

Hanasaki K, Arita H . Phospholipase A2 receptor: a regulator of biological functions of secretory phospholipase A2. Prostaglandins Other Lipid Mediat. 2002; 68-69:71-82. DOI: 10.1016/s0090-6980(02)00022-9. View

16.

Kuzmina N, Volynsky P, Boldyrev I, Alekseeva A . sPLA2 Wobbles on the Lipid Bilayer between Three Positions, Each Involved in the Hydrolysis Process. Toxins (Basel). 2022; 14(10). PMC: 9610741. DOI: 10.3390/toxins14100669. View

17.

Rosenson R, Fraser H, Trias J, Hislop C . Varespladib methyl in cardiovascular disease. Expert Opin Investig Drugs. 2010; 19(10):1245-55. DOI: 10.1517/13543784.2010.517193. View

18.

Faure G, Gowda V, Maroun R . Characterization of a human coagulation factor Xa-binding site on Viperidae snake venom phospholipases A2 by affinity binding studies and molecular bioinformatics. BMC Struct Biol. 2007; 7:82. PMC: 2248580. DOI: 10.1186/1472-6807-7-82. View

19.

Dennis E . Kinetic dependence of phospholipase A 2 activity on the detergent Triton X-100. J Lipid Res. 1973; 14(2):152-9. View

20.

Stahelin R, Cho W . Differential roles of ionic, aliphatic, and aromatic residues in membrane-protein interactions: a surface plasmon resonance study on phospholipases A2. Biochemistry. 2001; 40(15):4672-8. DOI: 10.1021/bi0020325. View